Identification and Characterization of Cefazolin-Induced Liver Injury
Year: 2014
Type: article
Study design: Observational Study
Language: English
Subfield: Pharmacology
Domain: Life Sciences
Open Access status: green
Awards: UT Southwestern Center for Translational Medicine (UL1/KL2/TL1), G2411765067, Indiana Clinical and Translational Sciences Institute, UT Southwestern: Clinical Site for the Drug-Induced Liver Injury Network, G3229079822, Uppper Midwest Drug Hepatoxicity Consortium, "Drug Induced Liver Injury Network", Research Network for Drug-Induced Liver Disease, Michigan Institute for Clinical and Health Research (MICHR) (UL1), North and Central Texas Clinical and Translational Science Initiative (UL1), Indiana Clinical and Translational Science Institute (UL1), G5043941941, Institutional Clinical and Translational Science Award, UNC Clinical and Translational Science Award, Michigan Institute for Clinical and Health Research (MCHR), G8225691149, Mayo Clinic Center for Translational Science Activities, Herbal and Dietary Supplement Induced Liver Injury in the U.S., University of North Carolina Clinical Center for DILIN, USC-UCLA Drug-Induced Liver Injury (DILI) Clinical Center, Michigan Hepatotoxicity Clinical Research Network Renewal, IU Clinical Center: Drug Induced Liver Injury Network, Drug Induced Liver Injury Network Data Coordinating Center
OpenAlex ID: W2152034160
